Literature DB >> 18425773

Netrin-1 can affect morphogenesis and differentiation of the mouse mammary gland.

Luigi Strizzi1, Mario Mancino, Caterina Bianco, Ahmed Raafat, Monica Gonzales, Brian W Booth, Kazuhide Watanabe, Tadahiro Nagaoka, David L Mack, Beatrice Howard, Robert Callahan, Gilbert H Smith, David S Salomon.   

Abstract

Netrin-1 has been shown to regulate the function of the EGF-like protein Cripto-1 (Cr-1) and affect mammary gland development. Since Cr-1 is a target gene of Nanog and Oct4, we investigated the relationship between Netrin-1 and Cr-1, Nanog and Oct4 during different stages of development in the mouse mammary gland. Results from histological analysis show that exogenous Netrin-1 was able to induce formation of alveolar-like structures within the mammary gland terminal end buds of virgin transgenic Cripto-1 mice and enhance mammary gland alveologenesis in early pregnant FVB/N mice. Results from immunostaining and Western blot analysis show that Netrin-1, Nanog and Oct4 are expressed in the mouse embryonic mammary anlage epithelium while Cripto-1 is predominantly expressed outside this structure in the surrounding mesenchyme. We find that in lactating mammary glands of postnatal FVB/N mice, Netrin-1 expression is highest while Cripto-1 and Nanog levels are lowest indicating that Netrin-1 may perform a role in the mammary gland during lactation. HC-11 mouse mammary epithelial cells stimulated with lactogenic hormones and exogenous soluble Netrin-1 showed increased beta-casein expression as compared to control thus supporting the potential role for Netrin-1 during functional differentiation of mouse mammary epithelial cells. Finally, mouse ES cells treated with exogenous soluble Netrin-1 showed reduced levels of Nanog and Cripto-1 and higher levels of beta-III tubulin during differentiation. These results suggest that Netrin-1 may facilitate functional differentiation of mammary epithelial cells and possibly affect the expression of Nanog and/or Cripto-1 in multipotent cells that may reside in the mammary gland.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18425773      PMCID: PMC4209409          DOI: 10.1002/jcp.21462

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  49 in total

Review 1.  Epigenetic alchemy for cell fate conversion.

Authors:  Toru Kondo
Journal:  Curr Opin Genet Dev       Date:  2006-07-17       Impact factor: 5.578

Review 2.  Nanog and transcriptional networks in embryonic stem cell pluripotency.

Authors:  Guangjin Pan; James A Thomson
Journal:  Cell Res       Date:  2007-01       Impact factor: 25.617

3.  Identification and analysis of in vitro cultured CD45-positive cells capable of multi-lineage differentiation.

Authors:  Ian Rogers; Nobuko Yamanaka; Ryszard Bielecki; Christine J Wong; Shawn Chua; Shelia Yuen; Robert F Casper
Journal:  Exp Cell Res       Date:  2007-03-12       Impact factor: 3.905

Review 4.  Controlled differentiation of stem cells.

Authors:  Nathaniel S Hwang; Shyni Varghese; Jennifer Elisseeff
Journal:  Adv Drug Deliv Rev       Date:  2007-10-11       Impact factor: 15.470

5.  Disruption of overlapping transcripts in the ROSA beta geo 26 gene trap strain leads to widespread expression of beta-galactosidase in mouse embryos and hematopoietic cells.

Authors:  B P Zambrowicz; A Imamoto; S Fiering; L A Herzenberg; W G Kerr; P Soriano
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

6.  Cripto-1 inhibits beta-casein expression in mammary epithelial cells through a p21ras-and phosphatidylinositol 3'-kinase-dependent pathway.

Authors:  M L De Santis; S Kannan; G H Smith; M Seno; C Bianco; N Kim; I Martinez-Lacaci; B Wallace-Jones; D S Salomon
Journal:  Cell Growth Differ       Date:  1997-12

Review 7.  The role of mammary stroma in modulating the proliferative response to ovarian hormones in the normal mammary gland.

Authors:  T L Woodward; J W Xie; S Z Haslam
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-04       Impact factor: 2.673

8.  Development of leiomyosarcoma of the uterus in MMTV-CR-1 transgenic mice.

Authors:  L Strizzi; C Bianco; M Hirota; K Watanabe; M Mancino; S Hamada; A Raafat; S Lawson; A D Ebert; A D'Antonio; S Losito; N Normanno; D S Salomon
Journal:  J Pathol       Date:  2007-01       Impact factor: 7.996

Review 9.  Stem cell pluripotency and transcription factor Oct4.

Authors:  Guang Jin Pan; Zeng Yi Chang; Hans R Schöler; Duanqing Pei
Journal:  Cell Res       Date:  2002-12       Impact factor: 25.617

10.  Signalling pathways implicated in early mammary gland morphogenesis and breast cancer.

Authors:  Beatrice Howard; Alan Ashworth
Journal:  PLoS Genet       Date:  2006-08-25       Impact factor: 5.917

View more
  12 in total

Review 1.  Cell-matrix interactions in mammary gland development and breast cancer.

Authors:  John Muschler; Charles H Streuli
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-08-11       Impact factor: 10.005

2.  Identification of myosin II as a cripto binding protein and regulator of cripto function in stem cells and tissue regeneration.

Authors:  Malachia Hoover; Farhana Runa; Evan Booker; Jolene K Diedrich; Erika Duell; Blake Williams; Caroline Arellano-Garcia; Toni Uhlendorf; Sa La Kim; Wolfgang Fischer; James Moresco; Peter C Gray; Jonathan A Kelber
Journal:  Biochem Biophys Res Commun       Date:  2018-12-20       Impact factor: 3.575

3.  Cripto-1 is a cell surface marker for a tumorigenic, undifferentiated subpopulation in human embryonal carcinoma cells.

Authors:  Kazuhide Watanabe; Matthew J Meyer; Luigi Strizzi; Joseph M Lee; Monica Gonzales; Caterina Bianco; Tadahiro Nagaoka; Shahram S Farid; Naira Margaryan; Mary J C Hendrix; Barbara K Vonderhaar; David S Salomon
Journal:  Stem Cells       Date:  2010-08       Impact factor: 6.277

4.  Cripto-1 ablation disrupts alveolar development in the mouse mammary gland through a progesterone receptor-mediated pathway.

Authors:  Malgorzata Klauzinska; David McCurdy; Maria Cristina Rangel; Arun Vaidyanath; Nadia P Castro; Michael M Shen; Monica Gonzales; Daniel Bertolette; Caterina Bianco; Robert Callahan; David S Salomon; Ahmed Raafat
Journal:  Am J Pathol       Date:  2015-10-01       Impact factor: 4.307

Review 5.  Role of Cripto-1 during epithelial-to-mesenchymal transition in development and cancer.

Authors:  Maria C Rangel; Hideaki Karasawa; Nadia P Castro; Tadahiro Nagaoka; David S Salomon; Caterina Bianco
Journal:  Am J Pathol       Date:  2012-04-26       Impact factor: 4.307

6.  Functional Roles of Netrin-1 in Osteoblast Differentiation.

Authors:  Tsuyoshi Sato; Shoichiro Kokabu; Yuichiro Enoki; Naoki Hayashi; Masahito Matsumoto; Mitsuhiko Nakahira; Masashi Sugasawa; Tetsuya Yoda
Journal:  In Vivo       Date:  2017 May-Jun       Impact factor: 2.155

7.  CrkII transgene induces atypical mammary gland development and tumorigenesis.

Authors:  Kelly E Fathers; Sonia Rodrigues; Dongmei Zuo; Indrani Vasudeva Murthy; Michael Hallett; Robert Cardiff; Morag Park
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

8.  Neuronal guidance protein Netrin-1 induces differentiation in human embryonal carcinoma cells.

Authors:  Mario Mancino; Claudia Esposito; Kazuhide Watanabe; Tadahiro Nagaoka; Monica Gonzales; Caterina Bianco; Nicola Normanno; David S Salomon; Luigi Strizzi
Journal:  Cancer Res       Date:  2009-02-17       Impact factor: 12.701

Review 9.  Axon guidance factor netrin-1 and its receptors regulate angiogenesis after cerebral ischemia.

Authors:  Qiao Ding; Song-Jie Liao; Jian Yu
Journal:  Neurosci Bull       Date:  2014-05-30       Impact factor: 5.203

10.  Netrin-1 promotes epithelium repair in corneal injury.

Authors:  Yun Han; Nan Jiang; Ting Su; Qi-Chen Yang; Cong-Cong Yan; Lei Ye; Qing Yuan; Pei-Wen Zhu; Wei Li; Zu-Guo Liu; Yi Shao
Journal:  Int J Ophthalmol       Date:  2020-02-18       Impact factor: 1.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.